Is there a future for electrochemically assisted hemodialysis? Focus on the application of polypyrrole-nanocellulose composites

Nanomedicine

Volumn 9, Issue 7, 2014, Pages 1095-1110

  Ferraz, Natalia ^a   Mihranyan, Albert ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

blood electrodialysis; Cladophora cellulose; hemodialysis; intrinsically conductive polymers; nanocellulose; polypyrrole

Indexed keywords

CELLULOSE; HEPARIN; NANOCELLULOSE; POLYMER; POLYPYRROLE; UNCLASSIFIED DRUG; NANOCOMPOSITE; PYRROLE DERIVATIVE;

AGING; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; ELECTROCHEMISTRY; ELECTRODIALYSIS; HEMODIALYSIS; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; REVIEW; SOLUTE; CHEMISTRY; ELECTROCHEMICAL ANALYSIS; PROCEDURES; RENAL REPLACEMENT THERAPY;

CELLULOSE; ELECTROCHEMICAL TECHNIQUES; NANOCOMPOSITES; POLYMERS; PYRROLES; RENAL DIALYSIS;

EID: 84903824924     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.49     Document Type: Review

References (128)

1. Vanholder R, Smet RD, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934-1943 (2003). (Pubitemid 36513344)
2. Bowry SK. Dialysis membranes today. Int. J. Arti. Org. 25(5), 447-460 (2002).
3. Ofsthun NJ. Limitations of membrane structure and dialyzer design on large solute removal in dialysis. Blood Purif. 18(4), 264-266 (2000).
4. Vienken J. Polymers in nephrology: characteristics and needs. Int. J. Art. Org. 25(5), 470-479 (2002).
5. Zweigart C, Neubauer M, Storr M, Böhler T, Krause B. Progress in the development of membranes for kidneyreplacement therapy. In: Comprehensive Membrane Sscience and Engneering, Drioli E, Giorno L (Eds). Elsevier BV, Oxford, UK, 351-390 (2010).
6. Schmid H, Schiffl H. Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on. Int. Urol. Nephr. 44(5), 1435-1440 (2012).
7. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J. A bench to bedside view of uremic toxins. J. Am. Soc. Nephr. 19(5), 863-870 (2008).
8. Sarnatskaya VV, Yushko LA, Sakhno LA et al. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients. Art. Cells, Blood Subst. Biotech. 35(3), 287-308 (2007).
9. Niwa T. Removal of protein bound uraemic toxins by hemodialysis. Blood Purif. 35(2), 20-25 (2013).
10. Fissell WH, Humes HD, Fleischman AJ, Roy S. Dialysis and nanotechnology: now, 10 years, or never? Blood Purif. 25, 12-17 (2007).
11. Humes HD, Fissell WH, Tiranathanagul K. The future of hemodialysis membranes. Kidney Int. 69, 1115-1119 (2006).
12. Leonard EF, Cortell S, Vitale NG. Membraneless dialysis- is it possible? Contr. Nephr. 149, 343-353 (2005).
13. Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R. Continuously functioning artificial nephron system: the promise of nanotechnology. Hemodial. Int. 9(3), 210-217 (2005). (Pubitemid 41131069)
14. Stamopoulos D. Magnetic nanoparticles utilized in hemodialysis for the treatment of hyperhomocysteinemia: the new challenge for nanobiotechnology. Curr. Nanosci. 4, 302-307 (2008).
15. Tijink MSL, Wester M, Sun J et al. A novel approach for blood purification: Mixed-matrix combining diffusion and adsorption in one step. Acta Biomat. 8, 2279-2287 (2012).
16. Leonard EF, West AC, Shapley NC, Larsen MU. Dialysis without membranes:how and why? Blood Purif. 22, 92-100 (2004).
17. Hedayat A, Elmoselhi H, Shoker A. Theoretical application of irreversible (nonequilibrium) thermodynamic principles to enhance solute fluxes across nanofabricated hemodialysis membranes. Int. J. Nephr. 2012, 718085 (2012).
18. Kokubo K, Otani Y, Tsukao H, Shibo T, Hirose M, Kobayashi H. Urea concentrating ability of artificial renal tubule based on countercurrent multiplyer system using electrodialysis, dialysis and filtration. IFMBE Proc. 25(7), 499-501 (2009).
19. Pirot F, Faivre V, Bourhis Y, Aulagner G, Falson F. Faster phenytoin removal from serum by electrodialysis: a potential use in hemodialysis? J. Memb. Sci. 207, 265-272 (2002).
20. Smith AL, Berkowitz HD, Bluemle LW Jr. Electrodialysis of blood: evaluation of a high capacity unit. Trans. Am. Soc. Art. Int. Org. 10, 273-279 (1964).
21. Bernhard A, Beaver JJ. The electrodialysis of human blood serum. J. Biol. Chem. 69, 113-124 (1926).
22. Lyttle D. Electrodialysis of blood using ion-exchange membranes. Ulster Med. J. 31, 79-81 (1962).
23. Sorrentino F. Die künstliche elektrodialytische Niere mit geschlossenem Kreislauf. Z. Urol. 9, 505-509 (1958).
24. Berkowitz H, Bluemle LW Jr. Electrodialysis: concept and preliminary studies of its application to blood. Trans. Am. Soc. Art. Int. Org. 8, 197-208 (1962).
25. Berkowitz H, Bluemle LW Jr. Electrodialysis of blood: Some problems and approaches to their solution. Trans. Am. Soc. Art. Int. Org. 9(1), 97-104 (1963).
26. Adachi R. The studies on the Jikei electro-dialyzer report 7: fundamental problems. Acta Urol. Jap. 7(2), 274-282 (1961).
27. Hosobe H. Studies on the newly devised Jikeikai College artificial kidney. Report 2. Acta Urol. Jap. 5, 179 (1959).
28. Kushimoto T. Studies on a newly devised artificial kidney (blood cleaner) report. 1. Acta Urol. Jap. 4(9), 509-512 (1958).
29. Matsumoto T. The studies on the Jikei electro-dialyzer report 6: the experimental study on the dialysis of the salicylate. Acta Urol. Jap. 6(11), 1059-1072 (1960).
30. Miki N. Studies on the newly devised jikeikai artificial kidney (blood cleaner). Report 3. The experimental studies on normal dogs and uremic dogs. Acta Urol. Japon. 5(3), 153-165 (1959).
31. Miki N. Studies on the Jikei electro-dialyzer report 5. The changes of the circulatory system during electrohemodialysis. Report 5. Acta Urol. Jap. 6(10), 859-881 (1960).
32. Miura Y. The Studies on the Jikei electro-dialyzer. Report 4. Fundamental problems. Acta Urol. Japon. 6(11), 1043-1058 (1960).
33. Ogata K. Studies om the Jikei electro-dialyzer: Report 8. Experimental studies of fundamental dialysing efficiency on the new type Jikei electrodialyzer with many dialysis chambers. Jap. J. Urol. 56(2), 176-197 (1965).
34. Miura Y. The studies on the Jikei electro-dialyzer. Report 4. Acta Urol. Japon. 6(11), 1043-1058 (1960).
35. Locatelli F, Manzoni C, Di Filippo S. The importance of convective transport. Kidney Int. (61 Suppl. 80), S115-S120 (2002).
36. Hintzen K, Stiller S, Brunner H, Rautenbach R, Mann H. Electrodialysis and reverse osmosis as a regeneration system for hemofiltrate. Art. Org. 7(2), 169-175 (1983).
37. Lin R, Ding YS, White JM et al. Hemodialysis and peritoneal dialysis systems having electrodialys and electrodeionization capabilities. 2013, 0186759A1 (2013).
38. Ferraz N, Carlsson DO, Hong J et al. Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification. J. R. Soc. Interf. 9(73), 1943-1955 (2012).
39. Ferraz N, Strømme M, Fellström B, Pradhan S, Nyholm L, Mihranyan A. In vitro and in vivo toxicity of rinsed and aged nanocellulose-polypyrrole composites. J. Biomed. Mat. Res. Pt A 100 A(8), 2128-2138 (2012).
40. Mihranyan A, Nyholm L, Garcia Bennett AE, Strømme M. A novel high specific surface area conducting paper material composed of polypyrrole and Cladophora cellulose. J. Phys. Chem. B 112(39), 12249-12255 (2008).
41. Mihranyan A. Cellulose from Cladophorales green algae: from environmental problem to high-tech composite materials. J. App. Polymer Sci. 119(4), 2449-2460 (2011).
42. Mihranyan A, Edsman K, Strømme M. Rheological properties of cellulose hydrogels prepared from Cladophora cellulose powder. Food Hydrocoll. 21(2), 267-272 (2007). (Pubitemid 44754881)
43. Strømme M, Frenning G, Razaq A, Gelin K, Nyholm L, Mihranyan A. Ionic motion in polypyrrole-cellulose composites: trap release mechanism during potentiostatic reduction. J. Phys.Chem. B 113(14), 4582-4589 (2009).
44. Gelin K, Mihranyan A, Razaq A, Nyholm L, Strømme M. Potential controlled anion absorption in a novel high surface area composite of Cladophora cellulose and polypyrrole. Electrochim. Acta 54(12), 3394-3401 (2009).
45. Loh IH, Moody RA, Huang JC. Electrically conductive membranes: synthesis and applications. J. Memb. Sci. 50(1), 31-49 (1990).
46. Shi W, Ma Y, Song C et al. Affinity electromembrane: electrically facilitated adsorption. J. Memb. Sci. 354(1-2), 86-92 (2010).
47. Wang J, Shi W, Jiang H, Wu G, Ruan C, Ge D. Heparindoped affinity electromembranes for thrombin purification. J. Memb. Sci. 373(1-2), 89-97 (2011).
48. Wang J, Wu G, Shi W et al. Affinity electromembrane with covalently coupled heparin for thrombin adsorption. J. Memb. Sci. 428, 70-77 (2013).
49. Razaq A, Mihranyan A, Welch K, Nyholm L, Strømme M. Influence of the type of oxidant on anion exchange properties of fibrous Cladophora cellulose/polypyrrole composites. J. Phys. Chem. B 113(2), 426-433 (2009).
50. Razaq A, Nyström G, Strømme M, Mihranyan A, Nyholm L. High-capacity conductive nanocellulose paper sheets for electrochemically controlled extraction of DNA oligomers. PLoS One 6(12), (2011).
51. Razaq A, Strømme M, Nyholm L, Mihranyan A. Electrochemically controlled separation of DNA oligomers with high surface area conducting paper electrode. ECS Trans. 35, 135-142 (2011).
52. Rubino S, Razaq A, Nyholm L, Strømme M, Leifer K, Mihranyan A. Spatial mapping of elemental distributions in polypyrrole-cellulose nanofibers using energy-filtered transmission electron microscopy. J. Phys. Chem. B 114(43), 13644-13649 (2010).
53. Winchester JF, Ronco C. Sorbent augmented hemodialysis systems: are we there yet? J. Am. Soc. Nephr. 21(2), 209-211 (2010).
54. Winchester JF, Ronco C, Brady JA et al. Sorbent augmented dialysis: minor addition or major advance in therapy? Blood Purif. 19(2), 255-259 (2001). (Pubitemid 32041364)
55. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif. Org. 18(5), 355-362 (1994). (Pubitemid 24167247)
56. Carlsson DO, Nyström G, Nyholm L, Mihranyan A, Strømme M. Development of nanocellulose/polypyrrole composites towards blood purification. Procedia Eng. 44, 733-736 (2012).
57. Carlsson DO, Mihranyan A, Strømme M, Nyholm L. Tailoring porosities and electrochemical properties of composites composed of microfibrillated cellulose and polypyrrole. RSC Adv. 4(17), 8489-8497 (2014).
58. Mihranyan A, Esmaeili M, Razaq A, Alexeichik D, Lindström T. Influence of the nanocellulose raw material characteristics on the electrochemical and mechanical properties of conductive paper electrodes. J. Mat. Sci. 47(10), 4463-4472 (2012).
59. Ferraz N, Leschinskaya A, Toomadj F, Fellström B, Strømme M, Mihranyan A. Membrane characterization and solute diffusion in porous composite nanocellulose membranes for hemodialysis. Cellulose 20(6), 2959-2970 (2013).
60. Vanholder R, Glorieux G, De Smet R, De Deyn PP. Low watersoluble uremic toxins. Adv. Ren. Repl. Ther. 10(4), 257-269 (2003).
61. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J. Am. Soc. Nephrol. 7(5), 728-736 (1996).
62. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N. Engl. J. Med. 329(14), 1001-1006 (1993). (Pubitemid 23307908)
63. Ward RA. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J. Am. Soc. Nephr. 16(8), 2421-2430 (2005).
64. Krieter DH, Canaud B. High permeability of dialysis membranes: what is the limit of albumin loss? Nephr. Dial. Transplant. 18(4), 651-654 (2003). (Pubitemid 36432243)
65. Boure T, Vanholder R. Which dialyser membrane to choose? Nephrol. Dial. Transplant. 19(2), 293-296 (2004). (Pubitemid 38195973)
66. Bouman CS, Van Olden RW, Stoutenbeek CP. Cytokine filtration and hemofiltration in four different membranes. Blood Purif. 16, 261-268 (1998).
67. Svirskis D, Travas-Sejdic J, Rodgers A, Garg S. Electrochemically controlled drug delivery based on intrinsically conducting polymers. J. Control. Release 146(1), 6-15 (2010).
68. Poole-Warren L, Goding J, Green R, Martens P. Challenges if therapeutic delivery using conducting polymers. Ther. Deliv. 3(4), 421-427 (2012).
69. Jeon G, Yang SY, Byun J, Kim JK. Electrically actuatable smart nanoporous membrane for pulsatile drug release. Nano Lett. 11(3), 1284-1288 (2011).
70. Richardson RT, Thompson B, Moulton S et al. The effect of polypyrrole with incorporated neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials 28(3), 513-523 (2007). (Pubitemid 44602239)
71. Richardson RT, Wise AK, Thompson BC et al. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30(13), 2614-2624 (2009).
72. Thompson BC, Moulton SE, Richardson RT, Wallace GG. Effect of the dopant anion in polypyrrole on nerve growth and release of a neurotrophic protein. Biomaterials 32(15), 3822-3831 (2011).
73. Abidian MR, Martin DC. Multifunctional nanobiomaterials for neural interfaces. Adv. Funct. Mat. 19(4), 573-585 (2009).
74. Hepel M, Fijalek Z. Electrorelease of neuroleptic drugs from composite polymer matrix. Proc. Contr. Rel. Soc. (25), 750-751 (1998).
75. Guiseppi-Elie A. Electroconductive hydrogels: Synthesis, characterization and biomedical applications. Biomaterials 31(10), 2701-2716 (2010).
76. Luo X, Cui XT. Electrochemically controlled release based on nanoporous conducting polymers. Electrochem. Comm. 11(2), 402-404 (2009).
77. Sharma M, Waterhouse GIN, Loader SWC, Garg S, Svirskis D. High surface area polypyrrole scaffolds for tunable drug delivery. Int. J. Pharm. 443(1-2), 163-168 (2013).
78. George PM, Lavan DA, Burdick JA, Chen CY, Liang E, Langer R. Electrically controlled drug delivery from biotindoped conductive polypyrrole. Adv. Mat. 18(5), 577-581 (2006). (Pubitemid 43385775)
79. Bidan G, Lopez C, Mendes-Viegas F, Vieil E, Gadelle A. Incorporation of sulphonated cyclodextrins into polypyrrole: an approach for the electro-controlled delivering of neutral drugs. Biosens. Bioel. 10(1-2), 219-229 (1995).
80. Boyle A, Genies E, Fouletier M. EIectrochemical behaviour of polypyrrole films doped with ATP anions. J. Electroanal. Chem. 279(1-2), 179-186 (1990).
81. Pyo M, Maeder G, Kennedy RT, Reynolds Jr. Controlled release of biological molecules from conducting polymer modified electrodes. The potential dependent release of adenosine 5′-triphosphate from poly(pyrrole adenosine 5′-triphosphate) films. J. Electroanal. Chem. 368(1-2), 329-332 (1994).
82. Xiao Y, Che J, Li CM et al. Preparation of nano-tentacle polypyrrole with pseudo-molecular template for ATP incorporation. J. Biomed. Mat. Res. Pt A 80(4), 925-931 (2007).
83. Li L, Huang C. Electrochemical/electrospray mass spectrometric studies of electrochemically stimulated ATP release from PP/ATP films. J. Am. Soc. Mass Spectr. 18(5), 919-926 (2007).
84. Kontturi K, Pentti P, Sundholm G. Polypyrrole as a model membrane for drug delivery. J. Electroanal. Chem. 453(1-2), 231-238 (1998). (Pubitemid 128411516)
85. Miller LL, Zhou QX. Poly(N-methylpyrrolylium) poly(styrenesulfonate). A conductive, electrically switchable cation exchanger that cathodically binds and anodically releases dopamine. Macromolecules 20(7), 1594-1597 (1987).
86. Zhou QX, Miller LL, Valentine Jr. Electrochemically controlled binding and release of protonated dimethyldopamine and other cations from poly(N-methylpyrrole)/ polyanion composite redox polymers. J. Electroanal. Chem. 261(1), 147-164 (1989).
87. Zinger B, Miller LL. Timed release of chemicals from polypyrrole films. J. Am. Chem.Soc. 106(22), 6861-6863 (1984).
88. Green RA, Lovell NH, Poole-Warren LA. Impact of coincorporating laminin peptide dopants and neurotrophic growth factors on conducting polymer properties. Acta Biomat. 6(1), 63-71 (2010).
89. Thompson BC, Moulton SE, Ding J et al. Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole. J. Control. Release 116(3), 285-294 (2006).
90. Li Y, Neoh KG, Kang ET. Controlled release of heparin from polypyrrole-poly(vinyl alcohol) assembly by electrical stimulation. J. Biomed. Mat. Res. Pt A 73(2), 171-181 (2005).
91. Esrafilzadeh D, Razal JM, Moulton SE, Stewart EM, Wallace GG. Multifunctional conducting fibres with electrically controlled release of ciprofloxacin. J. Control. Release 169(3), 313-320 (2013).
92. Sirivisoot S, Pareta R, Webster TJ. Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology 22(8), 085101 (2011).
93. Sirivisoot S, Pareta RA, Webster TJ. Electrically-controlled penicillin/streptomycin release from nanostructured polypyrrole coated on titanium for orthopedic implants. Solid St. Phen. Nanocomp. Mat. 151, 197-202 (2009).
94. Wadhwa R, Lagenaur CF, Cui XT. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J. Control. Release 110(3), 531-541 (2006).
95. Abidian MR, Kim DH, Martin DC. Conducting-polymer nanotubes for controlled drug release. Adv. Mat. 18(4), 405-409 (2006).
96. Svirskis D, Sharma M, Yu Y, Garg S. Electrically switchable polypyrrole film for the tunable release of progesterone. Ther. Deliv. 4(3), 307-313 (2013).
97. Ameli A, Alizadeh N. Nanostructured conducting molecularly imprinted polymer for selective uptake/release of naproxen by the electrochemically controlled sorbent. Anal. Biochem. 428(2), 99-106 (2012).
98. Hepel M, Mahdavi F. Application of the electrochemical quartz crystal microbalance for electrochemically controlled binding and release of chlorpromazine from conductive polymer matrix. Microchem. J. 56(1), 54-64 (1997). (Pubitemid 127402413)
99. Svirskis D, Wright BE, Travas-Sejdic J, Rodgers A, Garg S. Development of a controlled release system for risperidone using polypyrrole: mechanistic studies. Electroanalysis 22(4), 439-444 (2010).
100. Svirskis D, Wright BE, Travas-Sejdic J, Rodgers A, Garg S. Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system. Sens Actuators B Chem 151(1), 97-102 (2010).
101. Bugge JF. Influence of renal replacement therapy on pharmacokinetics in critically ill patients. Best Pract. Res. Clin. Anaesthes. 18(1), 175-187 (2004). (Pubitemid 38949991)
102. Sefer S, Degoricija V. About drug dialyzability. Acta Clinica Croat. 42(3), 257-267 (2003). (Pubitemid 38004809)
103. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25(26), 5681-5703 (2004). (Pubitemid 38624449)
104. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. The role of complement in biomaterial-induced inflammation. Mol. Immunol. 44(1-3), 82-94 (2007). (Pubitemid 44647107)
105. Ekdahl KN, Lambris JD, Elwing H et al. Innate immunity activation on biomaterial surfaces: A mechanistic model and coping strategies. Adv. Drug Del. Rev. 63, 1042-1050 (2011).
106. Deangelis RA, Reis ES, Ricklin D, Lambris JD. Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis. Immunobiology 217(11), 1097-1105 (2012).
107. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime? Trends Immunol. 28(4), 184-192 (2007). (Pubitemid 46476881)
108. Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J. Role of contact system activation in hemodialyzerinduced thrombogenicity. Kidney Int. 60(5), 1972-1981 (2001). (Pubitemid 33000004)
109. Uda S, Mizobuchi M, Akizawa T. Biocompatible characteristics of high- performance membranes. In: High- Performance Membrane Dialyzers. Saito A, Kawanishi H, Yamashita AC, Mineshima M (Eds). Karger, Basel, Switzerland, 23-29 (2011).
110. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44(3), 484-494 (1993). (Pubitemid 23265215)
111. Erlenkotter A, Endres P, Nederlof B, Hornig C, Vienken J. Score model for the evaluation of dialysis membrane hemocompatibility. Art. Org. 32(12), 962-969 (2008).
112. Vienken J. Biomaterials for medical devices: are current hemo- or biocompatibility tests adequate? Materialwissenschaft und Werkstofftechnik 41, 1081-1085 (2010).
113. Ateh DD, Navsaria HA, Vadgama P. Polypyrrole-based conducting polymers and interactions with biological tissues. J. R. Soc. Interf. 3(11), 741-752 (2006).
114. Meng S, Rouabhia M, Shi G, Zhang Z. Heparin dopant increases the electrical stability, cell adhesion, and growth of conducting polypyrrole/poly(l,l-lactide) composites. J. Biomed. Mater. Res. A 87(2), 332-344 (2008).
115. Wang X, Gu X, Yuan C et al. Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J. Biomed. Mat. Res. Pt A 68A(3), 411-422 (2004).
116. Williams RL, Doherty PJ. A preliminary assessment of poly(pyrrole) in nerve guide studies. J. Mat. Sci. Mat. Med. 5, 429-433 (1994).
117. Vanholder R. Biocompatibility issues in hemodialysis. Clin. Mater. 10(1-2), 87-133 (1992).
118. Carlsson DO, Sjödin M, Nyholm L, Strømme M. A comparative study of the effects of rinsing and aging of polypyrrole/nanocellulose composites on their electrochemical properties. J. Phys. Chem. B 117(14), 3900-3910 (2013).
119. Maksymiuk K. Chemical reactivity of polypyrrole and its relevance to polypyrrole based electrochemical sensors. Electroanalysis 18, 1537-1551 (2006).
120. Park DS, Shim YB, Park SM. Degradation of electrochemically prepared polypyrrole in aqueous sulfuric acid. J. Electrochem. Soc. 140(3), 609-614 (1993).
121. Pud AA. Stability and degradation of conducting polymers in electrochemical systems. Synth. Metals 66(1), 1-18 (1994).
122. Li Y, Qian R. Electrochemical overoxidation of conducting polypyrrole nitrate film in aqueous solutions. Electrochim. Acta 45(11), 1727-1731 (2000). (Pubitemid 30550619)
123. Kaynak A, Rintoul L, G.A. G. Change of mechanical and electrical properties of polypyrrole films with dopant concetration and oxidative aging. Mat. Res. Bull. 35, 813-824 (2000).
124. Kuhn HH, Child AD, Kimbell WC. Toward real applications of conductive polymers. Synth. Metals 71, 2139-2142 (1995).
125. Larsson R. Heparin-binding to improve biocompatibility. In: Encyclopedia of Biomaterials and Biomedical Engineering (2nd Edition). Wnek GE, Bowlin GL (Eds). Informa Healthcare, London, UK, 753-761 (2008).
126. Chanard J, Lavaud S, Randoux C, Rieu P. New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol. Dial. Transplant. 18(2), 252-257 (2003). (Pubitemid 36181673)
127. Videm V, Mollnes TE, Fosse E et al. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. J. Thorac. Cardiovasc. Surg. 117(4), 794-802 (1999).
128. Nilsson B, Korsgren O, Lambris JD, Ekdahl KN. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol. 31(1), 32-38 (2010).